AnalystsFrank TakkinenFrank Takkinen's Stock Forecasts
AnalystsFrank Takkinen
Analyst Ranking
Bottom 4%
#4687 out of 4870 analysts
Average Return
-20.67%
Win Rate
26%15 out of 58
Risk vs Reward
Poor
Good
Frank Takkinen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Neuropace IncNPCE | +228.63% | $4.75 | $15.61 | 2023-02-21 - 2024-02-21 | Strong Buy |
Elutia IncELUT | +183.09% | $1.36 | $3.85 | 2023-09-27 - 2024-09-27 | Strong Buy |
Silk Road Medical IncSILK | +132.73% | $11.55 | $26.88 | 2024-01-02 - 2024-06-18 | Strong Buy |
Cellebrite DI LtdCLBT | +80.52% | $10.47 | $18.90 | 2024-04-18 - 2025-04-17 | Strong Buy |
Clearpoint Neuro IncCLPT | +45.66% | $6.22 | $9.06 | 2023-08-08 - 2024-08-08 | Strong Buy |
Frank Takkinen Analyst Color
Get additional color on Frank Takkinen's coverage of popular stocks
Frank Takkinen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cvrx IncCVRX | 7 | Strong Buy | $14.00 | +92.04% | Maintains | 24 days ago |
Lensar IncLNSR | 2 | Hold | $15.00 | +7.22% | Downgrades | a month ago |
Hyperfine IncHYPR | 1 | Strong Buy | $1.50 | +105.48% | Initiates Coverage On | a month ago |
Axogen IncAXGN | 1 | Strong Buy | $30.00 | +82.04% | Initiates Coverage On | 2 months ago |
Sight Sciences IncSGHT | 3 | Hold | $2.50 | -18.83% | Maintains | 2 months ago |
Cellebrite DI LtdCLBT | 3 | Strong Buy | $26.00 | +30.92% | Maintains | 3 months ago |
Clearpoint Neuro IncCLPT | 4 | Strong Buy | $30.00 | +115.67% | Maintains | 3 months ago |
Koru Medical Systems IncKRMD | 2 | Strong Buy | $5.00 | +81.82% | Maintains | 4 months ago |
Anteris Technologies Global CorpAVR | 1 | Strong Buy | $20.00 | +322.83% | Initiates Coverage On | 4 months ago |
Inspiremd IncNSPR | 1 | Strong Buy | $5.00 | +92.31% | Initiates Coverage On | 5 months ago |
Inotiv IncNOTV | 6 | Strong Buy | $4.00 | +102.02% | Upgrades | 7 months ago |
Tela Bio IncTELA | 2 | Strong Buy | $8.00 | +700.00% | Maintains | 9 months ago |
Artivion IncAORT | 2 | Strong Buy | $30.00 | +28.59% | Maintains | 10 months ago |
Elutia IncELUT | 2 | Strong Buy | $10.00 | +352.49% | Maintains | 10 months ago |
Silk Road Medical IncSILK | 2 | Hold | $27.50 | +0.04% | Downgrades | 10 months ago |
Pulmonx CorpLUNG | 1 | Strong Buy | $12.00 | +218.30% | Initiates Coverage On | a year ago |
Envoy Medical IncCOCH | 2 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Stereotaxis IncSTXS | 2 | Strong Buy | $4.00 | N/A | Maintains | a year ago |
Neuropace IncNPCE | 2 | Strong Buy | $12.00 | N/A | Reiterates | a year ago |
Inspire Medical Systems IncINSP | 1 | Strong Buy | $350.00 | N/A | Maintains | 2 years ago |
Icad IncICAD | 3 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Apyx Medical CorpAPYX | 3 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Biolase IncBIOL | 2 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Edap Tms SaEDAP | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Greenbrook Tms IncGBNHF | 1 | Strong Buy | $3.00 | N/A | Maintains | 2 years ago |
Pavmed IncPAVM | 2 | Strong Buy | $22.50 | N/A | Maintains | 2 years ago |
Apollo Endosurgery IncAPEN | 2 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Uphealth IncUPHL | 1 | Hold | $10.00 | N/A | Downgrades | 3 years ago |
Biotricity IncBTCY | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Science 37 Holdings IncSNCE | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 4 years ago |
Skylight Health Group IncSLHGF | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.